Ipsen to scoop up Memo Therapeutics and its kidney infection drug

Erik van den Berg, Memo Therapeutics CEO July 1, 2026 07:12 AM EDT Deals Ipsen to scoop up Memo Ther­a­peu­tics and its kid­ney in­fec­tion drug Ayisha Sharma News Reporter Ipsen is on an M&A roll. The French drug­mak­er an­nounced its sec­ond deal of the week, say­ing it would buy Memo … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER